Loading…

Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients

To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis. Retrospective observational case series. Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed....

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology 2018-12, Vol.196, p.18-25
Main Authors: Williams, Basil K., Di Nicola, Maura, Ferenczy, Sandor, Shields, Jerry A., Shields, Carol L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183
cites cdi_FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183
container_end_page 25
container_issue
container_start_page 18
container_title American journal of ophthalmology
container_volume 196
creator Williams, Basil K.
Di Nicola, Maura
Ferenczy, Sandor
Shields, Jerry A.
Shields, Carol L.
description To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis. Retrospective observational case series. Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. Observation Procedures: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. Main Outcome Measures: Clinical and imaging features and treatment strategies. Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58–82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%). Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes.
doi_str_mv 10.1016/j.ajo.2018.08.011
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2089855240</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002939418304537</els_id><sourcerecordid>2089855240</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVpabZJf0AvRcce4q1G65Wl9hSWbhNISQ7pWcjSONFiW1tJDuRP5DdXZrchp8LAMPC9B_MeIZ-ALYGB-Lpbml1YcgZyycoAvCELkI2qQCp4SxaMMV6plapPyIeUduUUTd28JyerwkohmwV5voo-0V_exvCAgxnvfRhMDsmnb3TT-9Fb05_TbT-FiMmiH-nFzNxHs394OqdmdPRmn2eKbopDxNEivQvDkXhN0y2aPBUbWlygLvyY0E7ZPyK9NdnjmNMZedeZPuHH4z4lv7c_7jaX1fXNz6vNxXVla1C5AuVqYKYWrVQoBF9Z1XBwTSNdy2tRtkDXApOdaKFjUnFuXYO2426tOMjVKfly8N3H8GfClPXgy3t9b0YMU9K8aOR6zWtWUDigJaKUInZ6H_1g4pMGpuca9E6XGvRcg2ZlAIrm89F-agd0L4p_uRfg-wHA8uSjx6iT9XN2zke0Wbvg_2P_FzRYmcc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2089855240</pqid></control><display><type>article</type><title>Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients</title><source>Elsevier</source><creator>Williams, Basil K. ; Di Nicola, Maura ; Ferenczy, Sandor ; Shields, Jerry A. ; Shields, Carol L.</creator><creatorcontrib>Williams, Basil K. ; Di Nicola, Maura ; Ferenczy, Sandor ; Shields, Jerry A. ; Shields, Carol L.</creatorcontrib><description>To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis. Retrospective observational case series. Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. Observation Procedures: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. Main Outcome Measures: Clinical and imaging features and treatment strategies. Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58–82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%). Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes.</description><identifier>ISSN: 0002-9394</identifier><identifier>EISSN: 1879-1891</identifier><identifier>DOI: 10.1016/j.ajo.2018.08.011</identifier><identifier>PMID: 30118687</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Female ; Fluorescein Angiography - methods ; Hemangioma - pathology ; Humans ; Iris - blood supply ; Iris Diseases - diagnostic imaging ; Iris Diseases - pathology ; Male ; Microvessels - pathology ; Middle Aged ; Retrospective Studies ; Tomography, Optical Coherence - methods ; Visual Acuity</subject><ispartof>American journal of ophthalmology, 2018-12, Vol.196, p.18-25</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183</citedby><cites>FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183</cites><orcidid>0000-0002-6209-4191 ; 0000-0002-3288-3632 ; 0000-0002-7257-026X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30118687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, Basil K.</creatorcontrib><creatorcontrib>Di Nicola, Maura</creatorcontrib><creatorcontrib>Ferenczy, Sandor</creatorcontrib><creatorcontrib>Shields, Jerry A.</creatorcontrib><creatorcontrib>Shields, Carol L.</creatorcontrib><title>Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients</title><title>American journal of ophthalmology</title><addtitle>Am J Ophthalmol</addtitle><description>To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis. Retrospective observational case series. Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. Observation Procedures: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. Main Outcome Measures: Clinical and imaging features and treatment strategies. Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58–82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%). Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Fluorescein Angiography - methods</subject><subject>Hemangioma - pathology</subject><subject>Humans</subject><subject>Iris - blood supply</subject><subject>Iris Diseases - diagnostic imaging</subject><subject>Iris Diseases - pathology</subject><subject>Male</subject><subject>Microvessels - pathology</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Tomography, Optical Coherence - methods</subject><subject>Visual Acuity</subject><issn>0002-9394</issn><issn>1879-1891</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kUFr3DAQhUVpabZJf0AvRcce4q1G65Wl9hSWbhNISQ7pWcjSONFiW1tJDuRP5DdXZrchp8LAMPC9B_MeIZ-ALYGB-Lpbml1YcgZyycoAvCELkI2qQCp4SxaMMV6plapPyIeUduUUTd28JyerwkohmwV5voo-0V_exvCAgxnvfRhMDsmnb3TT-9Fb05_TbT-FiMmiH-nFzNxHs394OqdmdPRmn2eKbopDxNEivQvDkXhN0y2aPBUbWlygLvyY0E7ZPyK9NdnjmNMZedeZPuHH4z4lv7c_7jaX1fXNz6vNxXVla1C5AuVqYKYWrVQoBF9Z1XBwTSNdy2tRtkDXApOdaKFjUnFuXYO2426tOMjVKfly8N3H8GfClPXgy3t9b0YMU9K8aOR6zWtWUDigJaKUInZ6H_1g4pMGpuca9E6XGvRcg2ZlAIrm89F-agd0L4p_uRfg-wHA8uSjx6iT9XN2zke0Wbvg_2P_FzRYmcc</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Williams, Basil K.</creator><creator>Di Nicola, Maura</creator><creator>Ferenczy, Sandor</creator><creator>Shields, Jerry A.</creator><creator>Shields, Carol L.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6209-4191</orcidid><orcidid>https://orcid.org/0000-0002-3288-3632</orcidid><orcidid>https://orcid.org/0000-0002-7257-026X</orcidid></search><sort><creationdate>201812</creationdate><title>Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients</title><author>Williams, Basil K. ; Di Nicola, Maura ; Ferenczy, Sandor ; Shields, Jerry A. ; Shields, Carol L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Fluorescein Angiography - methods</topic><topic>Hemangioma - pathology</topic><topic>Humans</topic><topic>Iris - blood supply</topic><topic>Iris Diseases - diagnostic imaging</topic><topic>Iris Diseases - pathology</topic><topic>Male</topic><topic>Microvessels - pathology</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Tomography, Optical Coherence - methods</topic><topic>Visual Acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williams, Basil K.</creatorcontrib><creatorcontrib>Di Nicola, Maura</creatorcontrib><creatorcontrib>Ferenczy, Sandor</creatorcontrib><creatorcontrib>Shields, Jerry A.</creatorcontrib><creatorcontrib>Shields, Carol L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, Basil K.</au><au>Di Nicola, Maura</au><au>Ferenczy, Sandor</au><au>Shields, Jerry A.</au><au>Shields, Carol L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients</atitle><jtitle>American journal of ophthalmology</jtitle><addtitle>Am J Ophthalmol</addtitle><date>2018-12</date><risdate>2018</risdate><volume>196</volume><spage>18</spage><epage>25</epage><pages>18-25</pages><issn>0002-9394</issn><eissn>1879-1891</eissn><abstract>To describe the clinical and imaging findings and treatment options in a series of patients with iris microhemangiomatosis. Retrospective observational case series. Setting: Single institution. Study Population: Twenty-two eyes of 14 consecutive patients with iris microhemangiomatosis were reviewed. Observation Procedures: Clinical examination and slit-lamp photography were performed on every patient. Anterior segment optical coherence tomography (AS-OCT), anterior segment optical coherence tomography angiography (AS-OCTA), anterior segment intravenous fluorescein angiography (AS-IVFA), and ultrasound biomicroscopy were performed when possible. Main Outcome Measures: Clinical and imaging features and treatment strategies. Twenty-two eyes of 14 patients with iris microhemangiomatosis were included in this series. Mean patient age was 70 years (range, 58–82 years), and all patients were white. The iris hemangiomatosis appeared as subtle, multifocal, ectatic vascular channels arranged circumferentially at the pupillary margin. Iris color was blue (n = 19 eyes) or green (n = 3 eyes), and the features were unilateral (n = 6 patients) or bilateral (n = 8 patients). Additional features included reduced visual acuity (n = 13 eyes), hyphema (n = 12 eyes), and glaucoma (n = 7 eyes). There was no history of ocular trauma or systemic vasculopathic conditions. AS-OCT documented the fine tuft at the pupillary margin, AS-OCTA showed vascular flow, and AS-IVFA demonstrated pupillary margin vascular lesions with mild staining. Observation was advised in 20 cases (91%), and argon laser photocoagulation was required for repetitive hyphema in 2 cases (9%). Iris microhemangiomatosis is a rare ocular condition, often manifesting with spontaneous unilateral hyphema and/or secondary glaucoma. AS-IVFA confirms the diagnosis, and intervention with laser photocoagulation is necessary in only 9% of eyes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30118687</pmid><doi>10.1016/j.ajo.2018.08.011</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-6209-4191</orcidid><orcidid>https://orcid.org/0000-0002-3288-3632</orcidid><orcidid>https://orcid.org/0000-0002-7257-026X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0002-9394
ispartof American journal of ophthalmology, 2018-12, Vol.196, p.18-25
issn 0002-9394
1879-1891
language eng
recordid cdi_proquest_miscellaneous_2089855240
source Elsevier
subjects Aged
Aged, 80 and over
Female
Fluorescein Angiography - methods
Hemangioma - pathology
Humans
Iris - blood supply
Iris Diseases - diagnostic imaging
Iris Diseases - pathology
Male
Microvessels - pathology
Middle Aged
Retrospective Studies
Tomography, Optical Coherence - methods
Visual Acuity
title Iris Microhemangiomatosis: Clinical, Fluorescein Angiography, and Optical Coherence Tomography Angiography Features in 14 Consecutive Patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A14%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Iris%20Microhemangiomatosis:%20Clinical,%20Fluorescein%20Angiography,%20and%20Optical%20Coherence%20Tomography%20Angiography%20Features%20in%2014%20Consecutive%20Patients&rft.jtitle=American%20journal%20of%20ophthalmology&rft.au=Williams,%20Basil%20K.&rft.date=2018-12&rft.volume=196&rft.spage=18&rft.epage=25&rft.pages=18-25&rft.issn=0002-9394&rft.eissn=1879-1891&rft_id=info:doi/10.1016/j.ajo.2018.08.011&rft_dat=%3Cproquest_cross%3E2089855240%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c419t-19d410a46b89e6623c9721d778db2467786edb108f6b1f08922cd7ecf2d592183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2089855240&rft_id=info:pmid/30118687&rfr_iscdi=true